MaaT Pharma SA (MAAT.PA)
EUR 8.1
(1.0%)
EUR 8.1
(1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.22 Million | 1.43 Million | 972 Thousand | - | 89.3 Thousand | 892 Thousand |
| Cost of Revenue | 573 Thousand | 339 Thousand | 166 Thousand | 164 Thousand | 97 Thousand | 79 Thousand |
| Gross Profit | 1.65 Million | 1.09 Million | 806 Thousand | -164 Thousand | -7696.00 | 813 Thousand |
| Operating Expenses | 21.59 Million | 14.64 Million | 9.69 Million | 5.25 Million | 4.96 Million | 4.4 Million |
| Selling, General and Administrative Expenses | 3 Million | 1.81 Million | 1.38 Million | 1.28 Million | 922 Thousand | 787 Thousand |
| Research and Development Expenses | 20.29 Million | 14.47 Million | 9.14 Million | 6.09 Million | 5.26 Million | 4.5 Million |
| Other Expenses | -1.7 Million | -1.64 Million | -830 Thousand | -2.13 Million | -1.22 Million | -892 Thousand |
| Cost and Expenses | 22.17 Million | 14.98 Million | 9.86 Million | 5.25 Million | 4.96 Million | 4.4 Million |
| Operating Income | -19.94 Million | -13.55 Million | -8.89 Million | -5.25 Million | -4.96 Million | -4.4 Million |
| Interest Expense | 413 Thousand | 185 Thousand | 121 Thousand | 45 Thousand | 20 Thousand | 71 Thousand |
| Income Tax Expense | -3.63 Million | 157 Thousand | 121 Thousand | 49 Thousand | 803 Thousand | 71 Thousand |
| Earnings before Tax | -23.35 Million | -13.71 Million | -9.01 Million | -5.3 Million | -5.84 Million | -4.47 Million |
| Net Income | -19.71 Million | -13.87 Million | -9.14 Million | -5.35 Million | -6.64 Million | -4.54 Million |
| Earnings Per Share Basic | -1.73 | -1.40 | -3.77 | -25.91 | -32.20 | -4.40 |
| Earnings Per Share Diluted | -1.73 | -1.40 | -3.77 | -25.91 | -32.20 | -4.40 |
| Weighted Average Shares Outstanding | 11.36 Million | 9.89 Million | 2.42 Million | 206.45 Thousand | 206.45 Thousand | 1.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.36 Million | 9.89 Million | 2.42 Million | 206.45 Thousand | 206.45 Thousand | 1.03 Million |
| Gross Margin | 0.74 | 0.76 | 0.83 | - | -0.09 | 0.91 |
| EBIT Margin | -8.86 | -9.16 | -8.82 | - | -55.36 | -4.85 |
| Profit Margin | -8.85 | -9.70 | -9.40 | - | -74.43 | -5.10 |
| EBITDA | -19.74 Million | -13.31 Million | -8.71 Million | -6.58 Million | -6.76 Million | -5.09 Million |
| Earnings Before Tax Margin | -8.95 | -9.48 | -9.15 | - | -55.60 | -4.94 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 860.5 Thousand | 860.5 Thousand | 2.22 Million | 425 Thousand | 425 Thousand | 1.37 Million |
| Cost of Revenue | 268.5 Thousand | 268.5 Thousand | 1.44 Million | 297 Thousand | 297 Thousand | 484 Thousand |
| Gross Profit | 592 Thousand | 592 Thousand | 784 Thousand | 128 Thousand | 128 Thousand | 894 Thousand |
| Operating Expenses | 6.97 Million | 6.97 Million | 25.39 Million | 5.83 Million | 5.83 Million | 12.16 Million |
| Selling, General and Administrative Expenses | 1.59 Million | 1.59 Million | - | 1.33 Million | 1.33 Million | 2.51 Million |
| Research and Development Expenses | 6.34 Million | 6.34 Million | - | 5.6 Million | 5.6 Million | 9.65 Million |
| Other Expenses | -967.5 Thousand | -967.5 Thousand | - | -1.1 Million | - | - |
| Cost and Expenses | 7.23 Million | 7.23 Million | 26.83 Million | 6.12 Million | 6.13 Million | 12.65 Million |
| Operating Income | -6.37 Million | -6.37 Million | -24.61 Million | -5.7 Million | -5.7 Million | -11.27 Million |
| Interest Expense | - | - | 402 Thousand | 254 Thousand | - | 159 Thousand |
| Income Tax Expense | -1.62 Million | - | -3.63 Million | -1.53 Million | - | -2.1 Million |
| Earnings before Tax | -6.42 Million | -6.42 Million | -23.35 Million | -5.64 Million | -5.64 Million | -10.53 Million |
| Net Income | -6.42 Million | -6.42 Million | -19.71 Million | -5.64 Million | -5.64 Million | -8.43 Million |
| Earnings Per Share Basic | -0.53 | -0.53 | - | -0.49 | -0.49 | -0.76 |
| Earnings Per Share Diluted | -0.53 | -0.53 | - | -0.49 | -0.49 | -0.76 |
| Weighted Average Shares Outstanding | 12.19 Million | 12.19 Million | 11.36 Million | 11.59 Million | 11.59 Million | 11.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.19 Million | 12.19 Million | 11.36 Million | 11.59 Million | 11.59 Million | 11.13 Million |
| Gross Margin | 0.69 | 0.69 | 0.35 | 0.30 | 0.30 | 0.65 |
| EBIT Margin | -7.34 | -7.34 | - | -13.30 | -13.30 | -8.04 |
| Profit Margin | -7.47 | -7.47 | -8.85 | -13.27 | -13.27 | -6.12 |
| EBITDA | -6.31 Million | -6.31 Million | - | -5.65 Million | -5.65 Million | -11.07 Million |
| Earnings Before Tax Margin | -7.41 | -7.41 | -11.05 | -13.42 | -13.42 | -8.18 |
HIKAL
0591
EVSBY
004360
HOLM-B
4333